One prostate cancer patient showed a complete prostate-specific antigen (PSA) response with bone scan normalization for more than 5 years, and a heavily pretreated uterine carcinosarcoma patient was progression free for 1.5 years. This evidence concerns the gene KLK3 and prostate carcinoma.